Articles dans des revues avec comité de lecture (19)
12.
Van Woensel, M., Mathivet, T., Wauthoz, N., Rosiere, R., Garg, A. D., Agostinis, P., Mathieu, V., Kiss, R., Lefranc, F., Boon, L., Belmans, J., Van Gool, S. W., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2017). Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Scientific Reports, 27(1), 1217. doi:10.1038/s41598-017-01279-113.
Levet, V., Merlos, R., Rosiere, R., Amighi, K., & Wauthoz, N. (2017). Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties. International journal of pharmaceutics, 517, 359-372. doi:10.1016/j.ijpharm.2016.12.03714.
Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2016). Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of gliobmastoma multiforme via intranasal administration. Journal of controlled release, 227, 71-81. doi:10.1016/j.jconrel.2016.02.03215.
Rosiere, R., Van Woensel, M., Mathieu, V., Langer, I., Mathivet, T., Vermeersch, M., Amighi, K., & Wauthoz, N. (2016). Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy. International journal of pharmaceutics. doi:10.1016/j.ijpharm.2016.01.07316.
Levet, V., Rosiere, R., Merlos, R., Fusaro, L., Berger, G., Amighi, K., & Wauthoz, N. (2016). Development of Controlled-Release Cisplatin Dry Powders for Inhalation against Lung Cancers. International journal of pharmaceutics, 515(1-2), 209-220. doi:10.1016/j.ijpharm.2016.10.01917.
Rosiere, R., Gelbcke, M., Mathieu, V., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2015). New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy. International journal of oncology, 47(3), 1131. doi:10.3892/ijo.2015.309218.
Pilcer, G., Rosiere, R., Traina, K., Sebti, T., Vanderbist, F., & Amighi, K. (2013). New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients. Journal of pharmaceutical sciences, 102(6), DOI 10.1002/jps.23525 ABSTRACT:, 1836-46. doi:10.1002/jps.2352519.
Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., & De Vleeschouwer, S. (2013). Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel), 5(3), 1020-1048. doi:10.3390/cancers5031020 Communications publiées lors de congrès ou colloques nationaux et internationaux (8)
1.
Wauthoz, N., Chraibi, S., Davenne, T., Gerard, P., Rosiere, R., & Amighi, K. (2023). Evaluation of Tumour Exposure following the Administration of an Innovative Cisplatin Dry Powder for Inhalation at Different Dose Levels and Regimens. Journal of Aerosol Medicine and Pulmonary Drug Delivery.2.
Rosiere, R., Chraibi, S., Albasry, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2018). Development of paclitaxel nanocrystal-based dry powder formulations for targeted therapy of lung tumours by inhalation. Abstracts from the Aerosol Society Drug Delivery to the Lungs. Vol. 31 (2 ed., p. 5) Drug Delivery to the Lungs(28: 6-8 december 2018: Edinburg).4.
Levet, V., Rosiere, R., Hecq, J., Langer, I., Amighi, K., & Wauthoz, N. (2017). Tolerance of Cisplatin Dry Powders for Inhalation and Efficacy on an Orthotopic Grafted Lung Tumor Preclinical Model. In R. R. N. Dalby, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2017 (pp. 335-340) Virginia, USA: Virginia Commonwealth University.